Saul Levin, M.D., Will Be Next APA Medical Director/CEO
The APA Board of Trustees announced today that it has chosen Saul Levin, M.D., M.P.A., to be the Association's next medical director/CEO. Levin will replace James H. Scully Jr., M.D., who will step down when his contract is up later this year. Scully has served in that post for the last 12 years. Levin has served on several APA components including the Board of APA's political action committee (APAPAC), the Scientific Program Committee, and as a consultant to the Finance and Budget Committee. He has also been a member of the APA delegation to the AMA.
Levin currently is the interim director of the District of Columbia Department of Health and chair of the D.C. Essential Health Benefits Package Subcommitee of the Health Benefit Exchange Authority. He has also served as senior deputy director of the District of Columbia Addiction and Recovery Administration. Before taking on his positions in Washington, D.C., Levin was vice president for science, medicine, and public health at the AMA.
Commenting on Levin's selection as medical director, APA President-elect Jeffrey Lieberman, M.D., said, "Saul's expertise in electronic health information exchanges and implementation of the Affordable Care Act and meaningful-use requirements, as well as his commitment to mental health parity and proven leadership of large organizations, will be extremely important to APA and its members as we adapt to and continue our leadership role in health care reform." Scully commented that Levin "brings extraordinary intelligence, vision, and great energy to the challenges ahead for our profession. I look forward to working together with him as we transition to the news leadership." Levin will become CEO-designate in mid-July and will become medical director and CEO when Scully retires in the fall.
CMS Updates Information on Antipsychotic Use in Nu...
One Small Step Closer to Abolishing the SGR Formul...
CMS Won't Approve VNS Therapy for Depression Treat...
Ketamine-Related Compound Studied for Antidepressa...
Childhood ADHD Associated With Adult Obesity, Stud...
California Reports on Expected Premium Increases U...
Report Alerts Pediatricians to Mental Health Needs...
FDA Committee Approves New Insomnia Drug
Exposure to Suicide Predicts Increased Suicidality...
APA Responds to Oklahoma Tornado
Psychologist Prescribing Bill Dies in Illinois Leg...
Antipsychotics Being Recalled in Canada
President Bill Clinton Discusses MH Care at APA An...
Award-Winning Author Discusses Living With Schizop...
APA Leaders Pay Tribute To Jay Scully, M.D., as He...
Change in Annual Meeting Session With President Bi...
APA Releases DSM-5 Today
DEA Schedules Three More Cannabinoid Drugs
CDC Issues Major Report on Mental Illness Prevalen...
New Approach Raises Hope for Development of Heroin...
Brain Injury Appears to Increase Risk for Suicidal...
Saul Levin, M.D., Will Be Next APA Medical Directo...
Youth With Conduct Disorder More Likely to Abuse S...
Lieberman, Insel Issue Joint Statement About DSM-5...
Literature Review Supports Dropping Schizophrenia ...
Using Alcohol to Temper Mood Increases Dependence ...
Mental Illness Stigma a Global Concern, Internatio...
CDC Reports Data on Confusion, Memory Loss, Functi...
Pharmacologic Augmentation Can Aid Smokers Who Fai...
Mom's Flu May Influence Chance of Bipolar Disorder...
Infants' Inconsolable Crying Increases Postpartum ...
New Intervention for Suicide Attempters Can Facili...
Transgender Individuals Say They Need Better Acces...
David Kupfer, M.D., Responds to Criticism of DSM-5...
Gene-Deactivation Finding May Be Clue in Alzheimer...
Zolpidem Use Increasingly Ends in Emergency Room V...
Suicide Rate Jumps Among Middle-Aged Americans
Patients' Self-Assessment May Help Assess Violence...
Vermont Court First to Rule in Mental Health Parit...
Late-Life Depression Often Comorbid With Dementia
SSRIs May Increase Risk of Postsurgical Adverse Ef...